Multi-dose vial: difference between revisions
Diff·revision 38 → 39·23:30, 13 Sep 2025
Difference between revision 38 and revision 39 of Multi-dose vial. 4 lines changed; the page grew by 398 bytes.
| Revision 38 — 11:54, 7 Sep 2025 CategoryBot (talk) bot: sort category members 20,489 bytes +405 | Revision 39 — 23:30, 13 Sep 2025 GlossaryGleb (talk) convert prose to table for comparability 20,887 bytes +398 | ||
|---|---|---|---|
| 133 | <ref name="ppmdv">PeptidePedia community reconstitution-practice tally, 2026 (self-reported; no sterility or preservative-effectiveness data; weak evidence — see [[Project:Sourcing_guidelines]]).</ref> | 133 | <ref name="ppmdv">PeptidePedia community reconstitution-practice tally, 2026 (self-reported; no sterility or preservative-effectiveness data; weak evidence — see [[Project:Sourcing_guidelines]]).</ref> |
| 134 | 134 | ||
| + | 135 | == Further reading == | |
| + | 136 | * Dolan SA, Felizardo G, Barnes S, et al. "APIC position paper: safe injection, infusion, and medication vial practices in health care." ''American Journal of Infection Control'' 38(3):167–172 (2010). | |
| + | 137 | * Meyer BK, Ni A, Hu B, Shi L. "Antimicrobial preservative use in parenteral products: past and present." ''Journal of Pharmaceutical Sciences'' 96(12):3155–3167 (2007). | |
| + | 138 | ||
| 135 | == See also == | 139 | == See also == |
| 136 | * [[Vial]] | 140 | * [[Vial]] |